Advanced company searchLink opens in new window

PORTON BIOPHARMA LIMITED

Company number 09331560

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
27 Sep 2022 CH01 Director's details changed for Mr Bruce Philip Pritchard on 8 August 2022
27 Sep 2022 AP01 Appointment of Mr Martin West as a director on 8 August 2022
26 Sep 2022 TM01 Termination of appointment of Barry Clare as a director on 5 August 2022
20 Jun 2022 SH01 Statement of capital following an allotment of shares on 31 March 2022
  • GBP 145,681,000
06 Apr 2022 AA Group of companies' accounts made up to 31 March 2021
06 Dec 2021 CS01 Confirmation statement made on 27 November 2021 with updates
03 Dec 2021 AP01 Appointment of Mr Michael Austin as a director on 23 November 2021
29 Nov 2021 TM01 Termination of appointment of Ian Stuart Muir as a director on 16 November 2021
16 Jun 2021 SH01 Statement of capital following an allotment of shares on 31 March 2021
  • GBP 85,338,000
16 Jun 2021 TM02 Termination of appointment of Nigel Richard Mowbray Mackie as a secretary on 31 March 2021
16 Jun 2021 SH01 Statement of capital following an allotment of shares on 31 March 2021
  • GBP 30,000,000
16 Jun 2021 SH01 Statement of capital following an allotment of shares on 31 March 2021
  • GBP 86,681,000
12 Apr 2021 AA Full accounts made up to 31 March 2020
18 Jan 2021 AP01 Appointment of Mr Ian Stuart Muir as a director on 18 January 2021
04 Jan 2021 TM01 Termination of appointment of Roger James Hinton as a director on 7 December 2020
30 Nov 2020 CS01 Confirmation statement made on 27 November 2020 with updates
14 Jul 2020 TM01 Termination of appointment of Donald Richard Gleave as a director on 14 July 2020
11 Jun 2020 AP01 Appointment of Mr Bruce Philip Pritchard as a director on 1 June 2020
09 Jun 2020 AP01 Appointment of Mr Martin Andrews as a director on 1 June 2020
14 Apr 2020 SH01 Statement of capital following an allotment of shares on 31 March 2020
  • GBP 76,476,000
06 Apr 2020 CH01 Director's details changed for Donald Richard Gleave on 3 April 2020
06 Apr 2020 CH01 Director's details changed for Roger James Hinton on 3 April 2020
14 Feb 2020 AP01 Appointment of Ms Rebecca Wilson as a director on 11 February 2020
23 Dec 2019 AA Full accounts made up to 31 March 2019
27 Nov 2019 CS01 Confirmation statement made on 27 November 2019 with updates